NASH PR. From paragraph 4: "Chris Recknor, M.D.
Post# of 148150
(Total Views: 586)
Posted On: 11/03/2021 10:19:24 AM
NASH PR.
From paragraph 4: "Chris Recknor, M.D., Senior Executive Vice President of Clinical Operations, commented, “We are encouraged by the preliminary results from the open label portion of our NASH trial. The CT1 reduction from baseline for these patients is approximately 40 msec,"
CT1 is not defined anywhere in the PR. Apparently the unit of measurement is milliseconds.
Is the PR directed toward an audience of One ===> Ohm20?
The necessary unscrambling is aggravating after this many years of holding. Outsource the proofreading duties. Plenty on this board could do it.
Hey Siri, you forgot to mention that the trial is open label.
Siri: Oh, sorry, I'll just add it to the first sentence of the PR. I'll put it at the very end. Is that OK? "...patients treated with leronlimab in its Phase 2 trial for NASH (nonalcoholic steatohepatitis) open label." Find any other trial description which uses that word order.
From paragraph 4: "Chris Recknor, M.D., Senior Executive Vice President of Clinical Operations, commented, “We are encouraged by the preliminary results from the open label portion of our NASH trial. The CT1 reduction from baseline for these patients is approximately 40 msec,"
CT1 is not defined anywhere in the PR. Apparently the unit of measurement is milliseconds.
Is the PR directed toward an audience of One ===> Ohm20?
The necessary unscrambling is aggravating after this many years of holding. Outsource the proofreading duties. Plenty on this board could do it.
Hey Siri, you forgot to mention that the trial is open label.
Siri: Oh, sorry, I'll just add it to the first sentence of the PR. I'll put it at the very end. Is that OK? "...patients treated with leronlimab in its Phase 2 trial for NASH (nonalcoholic steatohepatitis) open label." Find any other trial description which uses that word order.
(3)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼